MAR 16, 2020 2:39 PM PDT

Cannabis Reduces ADHD Med Use in New Study

WRITTEN BY: Julia Travers

As the legalization of medical cannabis increases in the U.S. and around the globe, its effects on a variety of conditions and behaviors are under examination. In Israel, medical marijuana was first approved for cancer patients, those with chronic pain, and others in the 90s. Use has since expanded, with tens of thousands of people registered as users and Israel's Ministry of Health funding related research. The Evelyn Gruss Lipper Charitable Foundation also funds studies in this area and recently backed an exploration of how medical cannabis use affected the prescription drug intake of Israeli ADHD patients. 

In the U.S., it is estimated that about 6.1 million children have been diagnosed with ADHD to date. ADHD symptoms “start in early childhood and continue into adulthood. In some cases, ADHD is not recognized or diagnosed until the person is an adult,” according to the Mayo Clinic

The recent study focused on 53 Israeli medical cannabis patients who had an ADHD diagnosis. Most had previously gotten the cannabis licenses in relation to chronic pain or cancer treatment. Participants who used medical marijuana were found to use fewer prescription drugs or to stop taking ADHD medications altogether. 

Cannabis consumers were divided into high- and low-dose groups and 27 different combinations of cultivar varieties were trialed. “The cannabinoids most associated with reduced or eliminated ADHD medication use” included CBN, THC, THCV and CBD, Marijuana Moment reported. 

“These findings reveal that the higher-dose consumption of MC components (phyto-cannabinoids and terpenes) is associated with ADHD medication reduction… However, more studies are needed in order to fully understand if cannabis and its constituents can be used for management of ADHD,” the authors concluded. Jeffrey Y. Hergenrather, Joshua Aviram, Yelena Vysotski, Salvatore Campisi-Pinto, Gil M. Lewitus and David Meiri conducted the research. “Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients,” was published in the Rambam Maimonides Medical Journal in January 2020.

Article Sources:

Rambam Maimonides Medical Journal

Marijuana Moment

Mayo Clinic

 

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
FEB 21, 2020
Health & Medicine
FEB 21, 2020
Frequent Cannabis Use Could Affect Driving Safety
A new study suggests that heavy marijuana users have the potential to be dangerous drivers. However, hazardous driving a ...
MAR 05, 2020
Cannabis Sciences
MAR 05, 2020
Why Seniors Use Cannabis
People over 50 are the fastest-growing group of cannabis users. As journalist Alex Halperin pointed out in The Guardian, ...
APR 25, 2020
Cannabis Sciences
APR 25, 2020
Researchers Trial Cannabis to Treat COVID-19
Researchers in Israel are investigating the potential for cannabis-derived products to treat patients with COVID-19. So ...
MAY 19, 2020
Cannabis Sciences
MAY 19, 2020
Does Cannabinoid Deficiency Cause Common Illness?
Cannabis products are a godsend for many suffering from chronic illness. They are able to resolve multiple issues from d ...
MAY 28, 2020
Cannabis Sciences
MAY 28, 2020
US Healthcare Workers Need More Cannabis Education
Cannabis products are becoming more and more mainstream. Despite this, researchers from the University of Alabama have f ...
MAY 28, 2020
Cannabis Sciences
MAY 28, 2020
Cannabis-Free CBD More Effective than Regular CBD
Commonly known to come from the cannabis plant or hemp, cannabidiol (CBD) can also be found in a range of other plants. ...
Loading Comments...